These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1108256)

  • 1. Serum lactic dehydrogenase and irreversible renal allograft rejection.
    Anderson CB; Groce MA; Mohapatra RN; Codd JE; Graff RJ; Gregory JG; Newton WT
    Surgery; 1976 Feb; 79(02):161-5. PubMed ID: 1108256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The value of lactic dehydrogenase as a predictor of early allograft survival.
    Roses J; Woods JE; Zincke H
    Am J Surg; 1977 Jun; 133(6):726-8. PubMed ID: 326076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic usefulness of serum lactic dehydrogenase and its fifth isoenzyme levels in carcinoma of the prostate.
    Ishibe T
    Int Urol Nephrol; 1976; 8(3):221-5. PubMed ID: 1002398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of cyclooxygenase-2 during acute human renal allograft rejection.
    Rangel EB; Moura LA; Franco MF; Pacheco-Silva A
    Clin Transplant; 2005 Aug; 19(4):543-50. PubMed ID: 16008603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lactic dehydrogenase and human renal allograft failure.
    Anderson CB; Codd JE; Graff RJ; Gregory JG; Groce MA; Newton WT
    Surgery; 1975 May; 77(5):674-9. PubMed ID: 1092021
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum amyloid A protein: a sensitive indicator of renal allograft rejection in humans.
    Maury CP; Teppo A; Eklund B; Ahonen J
    Transplantation; 1983 Nov; 36(5):501-4. PubMed ID: 6356513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinicopathologic importance of serum lactic dehydrogenase in patients with gastric cancer.
    Zhao Z; Han F; Yang S; Hua L; Wu J; Zhan W
    Dis Markers; 2014; 2014():140913. PubMed ID: 25530656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of urinary isoenzymes in baboon renal allografts and autografts.
    Groenewald JH; Bersohn I; van Zyl JA; Schoonees R; Weber HW; Retief CP; Murphy GP
    J Surg Oncol; 1969; 1(2):141-51. PubMed ID: 4329663
    [No Abstract]   [Full Text] [Related]  

  • 9. Non-invasive monitoring of kidney allograft rejection through IDO metabolism evaluation.
    Brandacher G; Cakar F; Winkler C; Schneeberger S; Obrist P; Bösmüller C; Werner-Felmayer G; Werner ER; Bonatti H; Margreiter R; Fuchs D
    Kidney Int; 2007 Jan; 71(1):60-7. PubMed ID: 17136028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A primate model of hyperacute renal allograft rejection.
    Busch GJ; Martins AC; Hollenberg NK; Wilson RE; Colman RW
    Am J Pathol; 1975 Apr; 79(1):31-56. PubMed ID: 1092189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of soluble CD30 in kidney graft recipients as predictors of acute allograft rejection.
    Ayed K; Abdallah TB; Bardi R; Abderrahim E; Kheder A
    Transplant Proc; 2006 Sep; 38(7):2300-2. PubMed ID: 16980071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allograft viability determined by enzyme analysis.
    Codd JE; Garvin PJ; Morgan R; Jellinek M; Newton WT
    Transplantation; 1979 Dec; 28(6):447-50. PubMed ID: 390783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serum levels of lactic dehydrogenase after renal transplants].
    de Lima JJ; do Amaral Torres JN; da Rocha AL; Saldanha RV
    AMB Rev Assoc Med Bras; 1978 Aug; 24(8):262-4. PubMed ID: 364556
    [No Abstract]   [Full Text] [Related]  

  • 14. Use of capecitabine to prevent acute renal allograft rejection in dog erythrocyte antigen-mismatched mongrel dogs.
    Milovancev M; Schmiedt CW; Bentley E; Schwab M; Dubielzig RR; Gendron-Fitzpatrick AP; McAnulty JF
    Vet Surg; 2007 Jan; 36(1):10-20. PubMed ID: 17214815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of acute renal allograft rejection in early post-transplantation period by soluble CD30.
    Dong W; Shunliang Y; Weizhen W; Qinghua W; Zhangxin Z; Jianming T; He W
    Transpl Immunol; 2006 Jun; 16(1):41-5. PubMed ID: 16701175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum hydroxybutyric dehydrogenase: a clinical guide to renal allograft rejection.
    Andrews AT; Coppola ED; Villegas GR
    Surg Forum; 1969; 20():274-5. PubMed ID: 4910593
    [No Abstract]   [Full Text] [Related]  

  • 17. [Behavior of lactate dehydrogenase isoenzymes after cadaveric renal homografts in humans].
    Procaccia S; Ortolani C
    Quad Sclavo Diagn; 1972 Mar; 8(1):171-82. PubMed ID: 4576975
    [No Abstract]   [Full Text] [Related]  

  • 18. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The diagnostic capacity of serum amyloid A protein for early recognition of kidney allograft rejection.
    Casl MT; Bulatovic G; Orlić P; Sabljar-Matovinović M
    Nephrol Dial Transplant; 1995 Oct; 10(10):1901-4. PubMed ID: 8592601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninvasive diagnosis of renal-allograft rejection by measurement of messenger RNA for perforin and granzyme B in urine.
    Li B; Hartono C; Ding R; Sharma VK; Ramaswamy R; Qian B; Serur D; Mouradian J; Schwartz JE; Suthanthiran M
    N Engl J Med; 2001 Mar; 344(13):947-54. PubMed ID: 11274620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.